CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Antonella Zucchetto, Hillarj Chivilò et al.|Blood|2020Cited by 62
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Valter Gattei, Annalisa Gaglio et al.|Leukemia|2024Cited by 6
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|HemaSphere|2024Cited by 1
CD49d Expression Is Included in a Revised 4-Factor Model Predicting Outcome in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Multi-Center Real-World ExperienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|Blood|2023Cited by 0